文献速递血液净化与透析

循环ANGPTL2水平与维持性血液透析患者死亡风险:前瞻性队列研究

Circulating angiopoietin-like protein 2 levels and mortality risk in patients receiving maintenance hemodialysis: a prospective cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

本研究为多中心前瞻性队列,纳入412例维持性血液透析患者,分析循环ANGPTL2水平与全因死亡风险的关系。经多因素调整后,高ANGPTL2水平与全因死亡风险升高独立相关(HR 2.04, 95%CI 1.10-3.77),在预后相对良好亚组中关联更强。

要点

  • 高循环ANGPTL2水平与维持性血透患者全因死亡风险独立相关。
  • 在年轻、透析龄短、非糖尿病等老化表型少的患者中关联更强。
  • ANGPTL2或可作为尿毒症患者早衰进展和死亡风险的标志物。

核心结论

  • 循环ANGPTL2水平与维持性血液透析患者全因死亡风险呈正相关。
  • ANGPTL2可能是尿毒症患者早衰进展及后续死亡风险的独特标志物,但显著老化表型者除外。

研究设计与样本

  • 多中心前瞻性队列研究,纳入412例维持性血液透析患者,395例纳入统计分析。
  • 循环ANGPTL2水平经对数转换后作为连续变量分析。

主要发现

  • 调整年龄、性别、透析龄、营养状态、代谢指标及hs-CRP后,高ANGPTL2水平与全因死亡风险升高相关(HR 2.04, 95%CI 1.10-3.77)。
  • 在预后相对良好患者中,高ANGPTL2水平与死亡风险关联更强(HR 3.06, 95%CI 1.86-5.03)。
  • 年轻患者(HR 7.99, 95%CI 3.55-18.01)、透析龄短者(HR 3.99, 95%CI 2.85-5.58)及非糖尿病患者(HR 5.15, 95%CI 3.19-8.32)中关联尤为显著。

临床怎么用

  • 对维持性血透患者可考虑检测循环ANGPTL2水平以辅助评估早衰进展和死亡风险。
  • 在年轻、透析龄短、非糖尿病等老化表型少的患者中,ANGPTL2的预后价值可能更突出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing hemodialysis treatment have a poor prognosis, as many develop premature aging. Systemic inflammatory conditions often underlie premature aging phenotypes in uremic patients. We investigated whether angiopoietin-like protein 2 (ANGPTL 2), a factor that accelerates the progression of aging-related and noninfectious inflammatory diseases, was associated with increased mortality risk in hemodialysis patients. METHODS: We conducted a multicenter prospective cohort study of 412 patients receiving maintenance hemodialysis and evaluated the relationship between circulating ANGPTL2 levels and the risk for all-cause mortality. Circulating ANGPTL2 levels were log-transformed to correct for skewed distribution and analyzed as a continuous variable. RESULTS: Of 412 patients, 395 were included for statistical analysis. Time-to-event data analysis showed high circulating ANGPTL2 levels were associated with an increased risk for all-cause mortality after adjustment for age, sex, hemodialysis vintage, nutritional status, metabolic parameters and circulating high-sensitivity C-reactive protein levels {hazard ratio [HR] 2.04 [95% confidence interval (CI) 1.10-3.77]}. High circulating ANGPTL2 levels were also strongly associated with an increased mortality risk, particularly in patients with a relatively benign prognostic profile [HR 3.06 (95% CI 1.86-5.03)]. Furthermore, the relationship between circulating ANGPTL2 levels and mortality risk was particularly strong in patients showing few aging-related phenotypes, such as younger patients [HR 7.99 (95% CI 3.55-18.01)], patients with a short hemodialysis vintage [HR 3.99 (95% CI 2.85-5.58)] and nondiabetic patients [HR 5.15 (95% CI 3.19-8.32)]. CONCLUSION: We conclude that circulating ANGPTL2 levels are positively associated with mortality risk in patients receiving maintenance hemodialysis and that ANGPTL2 could be a unique marker for the progression of premature aging and subsequent mortality risk in uremic patients, except those with significant aging-related phenotypes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Morinaga J, Kakuma T, Fukami H, et al. Circulating angiopoietin-like protein 2 levels and mortality risk in patients receiving maintenance hemodialysis: a prospective cohort study. Nephrol Dial Transplant. 2020. PMID: 31840173. doi:10.1093/ndt/gfz236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。